During the last three months, 8 analysts shared their evaluations of Abbott Laboratories (NYSE:ABT), revealing diverse outlooks from bullish to bearish. The table below provides a concise overview ...

Abbott Laboratories' (NYSE:ABT) stock is up by a considerable 21% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we decided to study the company ...

Abbott Laboratories recently experienced a 20% price increase over the last quarter. This uptick coincides with several noteworthy developments, including Abbott's collaboration with Cadrenal ...